Charan V Devarakonda1, Flavia E Pereira1, Jonathan D Smith2, Linda H Shapiro3, Mallika Ghosh4. 1. Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT, 06030, USA. 2. Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. 3. Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT, 06030, USA. Electronic address: lshapiro@uchc.edu. 4. Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT, 06030, USA. Electronic address: mghosh@uchc.edu.
Abstract
BACKGROUND AND AIMS: Atherosclerosis is an inflammatory cardiovascular disorder characterized by accumulation of lipid-loaded macrophages in the intima. Prolonged accumulation leads to apoptosis of macrophages and eventually to progression of lesion development. Prevention of macrophage accumulation within the intima has been shown to reduce lesion formation. Since CD13 mediates trafficking of macrophages to sites of injury and repair, we tested the role of CD13 in atherosclerosis. METHODS: CD13+/+Ldlr-/- and CD13-/-Ldlr-/- (low density lipoprotein receptor) mice were fed basal or high fat diet (HFD) for 9, 12 and 15 weeks. Mice were euthanized and aortic roots along with innominate arteries were analyzed for atherosclerotic lesions. Cellular mechanisms were determined in vitro using CD13+/+ and CD13-/- bone marrow derived macrophages (BMDMs) incubated with highly oxidized low-density lipoprotein (oxLDL). RESULTS: At the 9 and 12 week time points, no differences were observed in the average lesion size, but at the 15 week time point, CD13-/-Ldlr-/- mice had larger lesions with exaggerated necrotic areas. CD13+/+ and CD13-/- macrophages endocytosed similar amounts of oxLDL, but CD13-/- macrophages generated higher amounts of oxidative stressors in comparison to CD13+/+ macrophages. This increased oxidative stress was due to increased nitric oxide production in oxLDL treated CD13-/- macrophages. Accumulated oxidative stress subsequently led to accelerated apoptosis and enhanced necrosis of oxLDL treated CD13-/- macrophages. CONCLUSIONS: Contrary to our prediction, CD13 deficiency led to larger atherosclerotic lesions with increased areas of necrosis. Mechanistically, CD13 deficiency led to increased nitric oxide production and consequently, greater oxidative stress.
BACKGROUND AND AIMS: Atherosclerosis is an inflammatory cardiovascular disorder characterized by accumulation of lipid-loaded macrophages in the intima. Prolonged accumulation leads to apoptosis of macrophages and eventually to progression of lesion development. Prevention of macrophage accumulation within the intima has been shown to reduce lesion formation. Since CD13 mediates trafficking of macrophages to sites of injury and repair, we tested the role of CD13 in atherosclerosis. METHODS:CD13+/+Ldlr-/- and CD13-/-Ldlr-/- (low density lipoprotein receptor) mice were fed basal or high fat diet (HFD) for 9, 12 and 15 weeks. Mice were euthanized and aortic roots along with innominate arteries were analyzed for atherosclerotic lesions. Cellular mechanisms were determined in vitro using CD13+/+ and CD13-/- bone marrow derived macrophages (BMDMs) incubated with highly oxidized low-density lipoprotein (oxLDL). RESULTS: At the 9 and 12 week time points, no differences were observed in the average lesion size, but at the 15 week time point, CD13-/-Ldlr-/- mice had larger lesions with exaggerated necrotic areas. CD13+/+ and CD13-/- macrophages endocytosed similar amounts of oxLDL, but CD13-/- macrophages generated higher amounts of oxidative stressors in comparison to CD13+/+ macrophages. This increased oxidative stress was due to increased nitric oxide production in oxLDL treated CD13-/- macrophages. Accumulated oxidative stress subsequently led to accelerated apoptosis and enhanced necrosis of oxLDL treated CD13-/- macrophages. CONCLUSIONS: Contrary to our prediction, CD13 deficiency led to larger atherosclerotic lesions with increased areas of necrosis. Mechanistically, CD13 deficiency led to increased nitric oxide production and consequently, greater oxidative stress.
Authors: Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman Journal: J Biol Chem Date: 2002-10-09 Impact factor: 5.157
Authors: Jaganathan Subramani; Mallika Ghosh; M Mamunur Rahman; Leslie A Caromile; Claire Gerber; Karim Rezaul; David K Han; Linda H Shapiro Journal: J Immunol Date: 2013-08-30 Impact factor: 5.422
Authors: Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona Journal: Nat Methods Date: 2012-06-28 Impact factor: 28.547
Authors: Dan Ye; Ying Zhao; Reeni B Hildebrand; Roshni R Singaraja; Michael R Hayden; Theo J C Van Berkel; Miranda Van Eck Journal: Am J Pathol Date: 2010-12-23 Impact factor: 4.307
Authors: Edward Thorp; Dongying Cui; Dorien M Schrijvers; George Kuriakose; Ira Tabas Journal: Arterioscler Thromb Vasc Biol Date: 2008-05-01 Impact factor: 8.311
Authors: Beata Winnicka; Catherine O'Conor; Wolfgang Schacke; Kaitlyn Vernier; Christina L Grant; Fiona Hall Fenteany; Flavia E Pereira; Brannen Liang; Anupinder Kaur; Ran Zhao; David C Montrose; Daniel W Rosenberg; Hector L Aguila; Linda H Shapiro Journal: J Leukoc Biol Date: 2010-04-29 Impact factor: 4.962